FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

2021000195106: Swiss French language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 07-Jun 2023. Module: SNOMED CT Switzerland NRC maintained Module

Descriptions:

Id Description Lang Type Status Case? Module
2061000195115 Swiss French language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
2071000195114 Swiss French language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
237201000195110 ensemble de référence pour la langue française suisse fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

303434 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Swiss French language reference set (foundation metadata concept) Is a French [International Organization for Standardization 639-1 code fr] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
123i-iode iobenguane Preferred (foundation metadata concept)
124I - iode 124 Acceptable (foundation metadata concept)
125I - iode 125 Acceptable (foundation metadata concept)
126I - iode 126 Acceptable (foundation metadata concept)
153sm-samarium lexidronam Acceptable (foundation metadata concept)
16 x 16 Preferred (foundation metadata concept)
16 x 22 Preferred (foundation metadata concept)
17 x 22 Preferred (foundation metadata concept)
17 x 25 Preferred (foundation metadata concept)
17-cétostéroïdes anormaux Preferred (foundation metadata concept)
18 x 22 Preferred (foundation metadata concept)
18 x 25 Preferred (foundation metadata concept)
18f-florbétabène Preferred (foundation metadata concept)
18f-fluorodopa Preferred (foundation metadata concept)
191Hg - mercure 191 Acceptable (foundation metadata concept)
192Hg - mercure 192 Acceptable (foundation metadata concept)
192Ir - iridium 192 Acceptable (foundation metadata concept)
193Hg - mercure 193 Acceptable (foundation metadata concept)
193mHg - mercure 193m Acceptable (foundation metadata concept)
194Hg - mercure 194 Acceptable (foundation metadata concept)
195Hg - mercure 195 Acceptable (foundation metadata concept)
195mHg - mercure 195m Acceptable (foundation metadata concept)
197Hg - mercure 197 Acceptable (foundation metadata concept)
1:03 Preferred (foundation metadata concept)
1:06 Preferred (foundation metadata concept)
1:1,5 Preferred (foundation metadata concept)
1:9 Preferred (foundation metadata concept)
1er étage Acceptable (foundation metadata concept)
2 heures Preferred (foundation metadata concept)
2,2,4-triméthyl-1,2-dihydroquinoline Preferred (foundation metadata concept)
2,3-époxy-1-propanol Preferred (foundation metadata concept)
2,4-DB Acceptable (foundation metadata concept)
2,4-DB - acide 4-(2,4-dichlorophénoxy)butyrique Acceptable (foundation metadata concept)
2,4-diisocyanate de toluène Preferred (foundation metadata concept)
2,4-imidazolidinedione Acceptable (foundation metadata concept)
2,4-toluènediamine Preferred (foundation metadata concept)
2,5-diaminotoluène sulfate Preferred (foundation metadata concept)
2,6-toluènediamine Preferred (foundation metadata concept)
2-(2-hydroxy-5-méthylphényl)benzotriazole Acceptable (foundation metadata concept)
2-acétylaminofluorine Preferred (foundation metadata concept)
2-amino-5-nitrothiazole Preferred (foundation metadata concept)
2-bromo-2-(bromométhyl)pentanedinitrile Acceptable (foundation metadata concept)
2-bromo-4-phénylphénol Preferred (foundation metadata concept)
2-chloro-4-nitrobenzamide Preferred (foundation metadata concept)
2-chloro-N-(hydroxyméthyl)acétamide Preferred (foundation metadata concept)
2-chloroéthanol Preferred (foundation metadata concept)
2-cyanoacrylate d'éthyle Preferred (foundation metadata concept)
2-cyanoacrylate de méthyle Acceptable (foundation metadata concept)
2-hydroxy-2,2-bis-(4-chlorophényl)éthyl acétate Preferred (foundation metadata concept)
2-hydroxy-4-méthoxy-4'-méthylbenzophénone Acceptable (foundation metadata concept)
2-hydroxy-4-méthoxybenzophénone Acceptable (foundation metadata concept)
2-hydroxybenzaldéhyde Acceptable (foundation metadata concept)
2-hydroxypropyl méthacrylate Acceptable (foundation metadata concept)
2-monométhylolphénol Preferred (foundation metadata concept)
2-méthoxy-p-crésol Preferred (foundation metadata concept)
2-méthyl-4-isothiazolin-3-one Preferred (foundation metadata concept)
2-méthylbutyrylglycinurie Preferred (foundation metadata concept)
2-phénylindole Preferred (foundation metadata concept)
2-phénylphénol Preferred (foundation metadata concept)
2-pivalyl-1,3-indandione Preferred (foundation metadata concept)
2-tert-butyl-4-methoxyphénol Preferred (foundation metadata concept)
2-éthylhexyl-2-cyano-3,3-diphénylacrylate Preferred (foundation metadata concept)
2-éthylhexyl-p-diméthylaminobenzoate Acceptable (foundation metadata concept)
201Tl - thallium 201 Acceptable (foundation metadata concept)
203Hg - mercure 203 Acceptable (foundation metadata concept)
21 x 25 Preferred (foundation metadata concept)
21-hydroxyprogestérone Acceptable (foundation metadata concept)
24 heures Preferred (foundation metadata concept)
25^e^ au 50^e^ centile Preferred (foundation metadata concept)
2e étage Acceptable (foundation metadata concept)
3 fois par jour, avant les repas Acceptable (foundation metadata concept)
3 fois par jour, avec les repas Acceptable (foundation metadata concept)
3 fois par jour, pendant les repas Acceptable (foundation metadata concept)
3,3'-diiodothyronine anormale Preferred (foundation metadata concept)
3,4,5-trihydroxybenzoate de propyle Acceptable (foundation metadata concept)
3,4-diaminopyridine Preferred (foundation metadata concept)
3,7,11-triméthyl-2,6,10-dodécatriène-1-ol Acceptable (foundation metadata concept)
3-(4-méthylbenzylidène)-camphre Acceptable (foundation metadata concept)
3-3,dichlorobenzidine Preferred (foundation metadata concept)
3-AMG (acidurie 3-méthylglutaconique) avec activité normale de la 3-méthylglutaconyl coenzyme A hydratase Acceptable (foundation metadata concept)
3-AMG (acidurie 3-méthylglutaconique) de type 8 Acceptable (foundation metadata concept)
3-AMG (acidurie 3-méthylglutaconique) de type 9 Acceptable (foundation metadata concept)
3-Methyl-4-(4?-nitrophenylazo)-N,N-bis(2-hydroxyethyl)aniline Acceptable (foundation metadata concept)
3-alpha-allo-tétrahydrocortisol Preferred (foundation metadata concept)
3-aminophénol Preferred (foundation metadata concept)
3-méthoxyaniline Preferred (foundation metadata concept)
3-méthylfentanyl Preferred (foundation metadata concept)
3-méthylphénol Acceptable (foundation metadata concept)
3-phényl-salicylate de cuivre Preferred (foundation metadata concept)
3-phénylpropénal Acceptable (foundation metadata concept)
3/4 de mouvement Preferred (foundation metadata concept)
30 mm Preferred (foundation metadata concept)
30-50 % de spermatozoïdes de morphologie normale Acceptable (foundation metadata concept)
3^e^ au 10^e^ centile Preferred (foundation metadata concept)
3e étage Acceptable (foundation metadata concept)
4 heures Preferred (foundation metadata concept)
4,4'-MDI Acceptable (foundation metadata concept)
4,4'-biphénol Acceptable (foundation metadata concept)
4,4'-diaminodiphénylméthane Preferred (foundation metadata concept)
4,4'-dihydroxybiphényle Preferred (foundation metadata concept)
4,4'-diisocyanate de diphénylméthane Preferred (foundation metadata concept)

Start Previous Page 5 of 3035 Next End

Reference Sets

Reference set descriptor

Back to Start